[1]
Aguilar, C. and Rodríguez-Delfín, L. 2014. Effects of spironolactone administration on the podocytes loss and progression of experimental diabetic nephropathy. Revista Peruana de Medicina Experimental y Salud Pública. 29, 4 (Feb. 2014). DOI:https://doi.org/10.17843/rpmesp.2012.294.393.